MedAware Systems’ Personalized Clinical Decision Support system provides healthcare professionals and their patients immediate and actionable information on medical treatments and outcomes. - iCrowdNewswire

RSS Newsfeeds

See all RSS Newsfeeds

Global Regions

United States ( XML Feed )

Jun 1, 2016 12:58 PM ET

MedAware Systems’ Personalized Clinical Decision Support system provides healthcare professionals and their patients immediate and actionable information on medical treatments and outcomes.

iCrowdNewswire - Jun 1, 2016

MedAware Systems, Inc. Logo


MedAware Systems, Inc.



Broomfield, CO 80020, US



MedAware Systems helps physicians make the best possible treatment decision for their patients.

MedAware Systems’ Personalized Clinical Decision Support system provides healthcare professionals and their patients immediate and actionable information on medical treatments and outcomes. This new Scientific-Data-as-a-Service (SDaaS)™ solves the problem of making the vast and chaotic body of human clinical trials research instantly available and indispensable in developing the patient plan of care.

Historically, the most current information on effective, evidence-based treatments typically takes ten years, or more, to bubble up into standards of medical practice. The cost of this in terms of patient outcome and dollars wasted is staggering. The monumental study conducted by Dr. Don Berwick and his research team estimated that incorrect or ineffective medical treatments cost the US over $350 Billion per year.

Ours is a competitively priced subscription model initially targeted for millions of healthcare professionals, and later, directly to hundreds of millions of their patients, who are driving 160 million medical searches per day on Google.

With the rapidly accelerating transition to Value-based healthcare in the US, there is now significant incentive for physicians and medical organizations to increase efficiency and improve patient outcome, coupled with financial penalties for not achieving better outcomes.

Our new data service is positioned to become the de facto standard for informing physicians on the most effective treatment for each individual patient they see – quickly (in under 45 seconds) and accurately. Subscribers are able to filter this vast amount of data to provide first-ever individualized treatment efficacy information based on a unique patient profile, i.e., age, sex, race, severity of the condition, co-morbidities, etc.






























Products / Services

Helping physicians make the best possible treatment decisions for their patients

Based on the life’s work of Founder and Chief Science Officer, Dr. Zung Vu Tran, one of world’s leading medical bio-statisticians, this subscription-based service will eliminate today’s time-consuming and inaccurate keyword searches with precise database queries based on patient specific and disease specific filters.

MedAware Systems’ service provides accurate analysis of data across tens, hundreds, or thousands of studies, and reports that information in a standardized and quickly understood format, at a button click.

In essence, doctors and patients have the ability to “read” tens, hundreds, or thousands of research studies in less than a minute. The reports generated offer the most comprehensive and recent scientific evidence on the efficacy of disease treatment for the specific patient.



Chief Science/Scientist
Dr. Zung Vu Tran

Dr. Tran was recently Research Professor of Biostatistics, Colorado School of Public Health, and Clinical Professor of Pediatrics, School of Medicine, University of Colorado, Anschutz Medical Campus. He has also served as Interim Director, Biostatistics & Data Management Core, University of Colorado Cancer Center, and Scientific Director, Biostatistics & Data Management Core, Children’s Hospital of Philadelphia.

Dr. Tran brings over 30 years’ experience in pharmaceutical and medical device industry settings. He is recognized as a leading authority in meta-analysis methodology. As a pioneer in this science of data extraction, integration and analysis, he was the first to publish a meta-analysis in the prestigious Journal of the American Medical Association. Dr. Tran was also the first scientist to receive a NIH R01 grant for developing and applying meta-analysis methodology. He specializes in the design and analysis of clinical trials, and management of large research databases.

Chief Executive Officer
Michael Willis

Michael has served in leadership positions for technology companies for over 30 years and has considerable experience and expertise developing technology products and services for a variety of markets. With a focus on product development, sales, marketing, and customer support he has built successful companies and led them to exit strategies that brought considerable value to investors and other stakeholders.

He was CEO at publicly traded Tombstone technologies; President of Digital Creators, which was acquired by TeleTech; Group Vice President for Production and Development for Jones Digital Century, a division of Jones Intercable, then the 5th largest cable company in the US; and the Vice President for Production for Philips Interactive Media, a division of Philips Electronics.

Chief Financial Officer
Neil A. Cox

Neil has more than three decades experience in the securities and financial industry. He brings a solid understanding of acquisitions, strategic planning, private and public financing.

He was the founder and served as CFO for Tombstone Technologies, a publicly traded software company developing SaaS software systems for the printing industry and acquired by Hunt Global Resources in 2010.

Neil founded, served as CFO and was instrumental in the financing and guidance process in making the company become publicly traded. The software company helped pioneer computerized medical records on the Internet. Its software was leading edge by using an interactive website that allowed for developing complete medical histories viewable on demand by health care providers.

Neil worked as an Investment Banker and was the owner of Rocky Mountain Securities & Investments, Inc. for over 20 years.





Prior Year RevenueCurrent Year RevenueNext Year Revenue



Company AgeEmployeesSub-Industry
2 years, 10 months26Healthcare Information Services



Company TypeStock ExchangeStock Symbol





Contact Information:

Michael Willis

View Related News >